APOE and Dravet syndrome: Given that recent evidence has demonstrated differences in brain development associated with risk for AD (APOE e4 allele) in infants and children with DS (Dean et al., 2014), more emphasis should be placed on the life-span progression to AD in both typical and DS-associated decline, beginning in infancy.